A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Condition(s):LeiomyosarcomaLast Updated:June 18, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):LeiomyosarcomaLast Updated:June 18, 2023Active, not recruiting
Condition(s):Advanced Solid TumorLast Updated:June 9, 2023Completed
Condition(s):Deleterious BRCA1 Gene Mutation; Deleterious BRCA2 Gene Mutation; Loss of Heterozygosity; Lung Non-Small Cell Squamous Carcinoma; Recurrent Large Cell Lung Carcinoma; Recurrent Lung Adenocarcinoma; Recurrent Lung Non-Small Cell Carcinoma; Recurrent Non-Squamous Non-Small Cell Lung Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:December 8, 2023Active, not recruiting
Condition(s):Cervical CancerLast Updated:November 1, 2019Withdrawn
Condition(s):Breast CancerLast Updated:August 2, 2023Active, not recruiting
Condition(s):Prostate Cancer MetastaticLast Updated:February 9, 2024Active, not recruiting
Condition(s):Pancreatic Cancer; Pancreatic Ductal AdenocarcinomaLast Updated:June 13, 2023Completed
Condition(s):Biliary Tract CancerLast Updated:August 31, 2023Active, not recruiting
Condition(s):Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Clear Cell CarcinomaLast Updated:November 21, 2023Active, not recruiting
Condition(s):Metastatic Breast CancerLast Updated:June 8, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.